PMV Pharma bags $74 mln Series B
Cranbury, New Jersey-based PMV Pharmaceuticals Inc, a developer of small molecule drugs that treat cancer, has closed $74 million in Series B financing. Topspin Biotech Fund led the round with participation from Euclidean Capital, InterWest Partners, OrbiMed Advisors and Osage University Partners.
23 February 2017•1 min read
